| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Research Abstract |
The aim of this study is to confirm the antiosteoporotic effect of DHNA in ovariectomized(OVX) mice. This study used female ICR OVX mice and female ICR sham operated mice. OVX mice were randomized into four groups : DHNA group, Vitamine K2(VK) group, Risedronate(Ris) group and control group. Histological and radiographical analysis showed that in the OVX group, the travecular bone was narrow and the bone marrow cavity was wide. On the other hand, these osteoporotic changes were improved in DHNA and Ris group. DHNA had some effects for improving bone mass reduction caused by osteoporosis and may become an alternative medicine for osteoporosis.
|
